Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 12/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 14/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.36 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690872 | 0.88 | CYP17A1 (0.42) | CYP17A1CYP3A4GABRA1GABRG2GABRB3 | |
| SCHEMBL4033550 | 0.84 | CYP17A1 (0.70) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4026821 | 0.83 | CYP17A1 (0.47) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5753882 | 0.81 | CYP3A4 (0.44) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4028225 | 0.80 | CYP3A4 (0.67) | CYP17A1CYP3A4CYP2C9CYP2C19GABRA1 | |
| SCHEMBL4028070 | 0.78 | CYP3A4 (0.50) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5751835 | 0.78 | CYP3A4 (0.44) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5752256 | 0.78 | CYP3A4 (0.44) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4028357 | 0.77 | CYP17A1 (0.42) | CYP17A1CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL5752772 | 0.77 | CYP3A4 (0.43) | CYP17A1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1222174-B1 | IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE | TAKEDA PHARMACEUTICAL (JP) | 2009-05-27 | — | — | EP | disclosed |
| EP-1222174-B1 | IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE | TAKEDA PHARMACEUTICAL (JP) | 2009-05-27 | — | — | EP | disclosed |
| US-6649643-B1 | Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-11-18 | — | — | US | disclosed |
| EP-1222174-A1 | IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE | Takeda Chemical Industries, Ltd. (JP) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001030762-A1 | IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-03 | — | — | WO | disclosed |